title: Coprescribing proton pump inhibitors with other medications.
abstract: Proton pump inhibitors, the treatment of choice for acid-related disorders, are often coadministered with other medications, sometimes with potentially adverse interactions. Although all agents studied may potentially interact with one proton pump inhibitor or another, a literature review documented adverse interactions for 10 medications in particular. Furthermore, 44% of people using proton pump inhibitors received another gastrointestinal drug. Although documented interactions involving these agents have been reported infrequently, the authors advise that physicians and pharmacists should recognize this possibility and watch for potentially problematic combination therapy.
authors.affiliation: Virginia Commonwealth University, Medical College of Virginia School of Pharmacy, Richmond, Virginia, USA. wgarnett@hsc.vcu.edu
authors.forename: W R
authors.initials: WR
authors.lastname: Garnett
authors.forename: J
authors.initials: J
authors.lastname: Prescott
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D004347:Drug Interactions; D011307:Drug Prescriptions; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008329:Managed Care Programs / Q000592:standards; D008508:Medication Errors; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D010593:Pharmaceutical Services / Q000458:organization & administration* / Q000592:standards; D054328:Proton Pump Inhibitors; D012189:Retrospective Studies
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole